BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/7/2020 5:03:30 AM | Browse: 953 | Download: 1214
 |
Received |
|
2020-02-09 21:27 |
|
Peer-Review Started |
|
2020-02-09 21:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-02-27 00:43 |
|
Revised |
|
2020-03-25 17:18 |
|
Second Decision |
|
2020-04-14 13:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-04-14 23:51 |
|
Articles in Press |
|
2020-04-14 23:51 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-04-29 00:08 |
|
Publish the Manuscript Online |
|
2020-05-07 05:03 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Minireviews |
| Article Title |
Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Adriano Carneiro da Costa, Mikael Sodergren, Kumar Jayant, Fernando Santa Cruz, Duncan Spalding, Madhava Pai and Nagy Habib |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nagy Habib, FRCS (Gen Surg), Chairman, Professor, Department of Surgery and Cancer, Faculty of Medicine, Hammersmith Hospital, Imperial College London, 1st Floor B Block, Du Cane Road, London W12 0NN, United Kingdom. nagy.habib@imperial.ac.uk |
| Key Words |
Hepatocellular carcinoma; Radiofrequency ablation; Immunotherapy; Liver cancer; Combined modality therapy; State-of-the-art review |
| Core Tip |
Radiofrequency ablation (RFA) is a well-established surgical approach to treat hepatocellular carcinoma (HCC). However, it has the inconvenience of being related to tumor recurrence. The combination of RFA and immunotherapy has emerged as a promising approach to activate and potentialize local and systemic immune responses. It has potential to reinstate anti-tumor immunity in HCC through increase in antitumor T cell response. The approach seems quite pragmatic in limiting the recurrence and improving survival rates compared to RFA alone for HCC patients. Currently, there are only eight articles in the literature that studied the combination of RFA and immunotherapy. |
| Publish Date |
2020-05-07 05:03 |
| Citation |
da Costa AC, Sodergren M, Jayant K, Santa Cruz F, Spalding D, Pai M, Habib N. Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations. World J Gastroenterol 2020; 26(17): 2040-2048 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i17/2040.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i17.2040 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
